Managed Account Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
$82.7M Buy
162,144
+21,928
+16% +$10.7M 0.07% 299
2015
Q1
$63.3M Buy
140,216
+65,630
+88% +$27.8M 0.06% 357
2014
Q4
$30.6M Buy
74,586
+3,863
+5% +$1.52M 0.03% 530
2014
Q3
$25.5M Buy
70,723
+3,734
+6% +$1.25M 0.03% 586
2014
Q2
$18.9M Sell
66,989
-51,265
-43% -$15.2M 0.02% 701
2014
Q1
$35.5M Buy
118,254
+354
+0.3% +$109K 0.05% 433
2013
Q4
$32.5M Sell
117,900
-21,322
-15% -$6.13M 0.04% 452
2013
Q3
$43.6M Buy
139,222
+11,183
+9% +$2.94M 0.06% 335
2013
Q2
$28.8M Buy
+128,039
New +$29.8M 0.04% 443

Other funds holding REGN